Our Parkinson's Place: New Biomarker assays for Parkinson’s Disease Granted EU Funds

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

Monday, February 15, 2016

New Biomarker assays for Parkinson’s Disease Granted EU Funds

February 15, 2016

Margarida Azevedo

European Union researchers, as a part of the EU-funded BIOMARKERS FOR PD project, have developed a Parkinson’s Disease (PD) biochemical biomarker assay that could lead to early diagnosis of the disease, the development of effective treatments and the successful assessment of pathogenesis and overall physiology of the disease.

Aside from the extreme social and mental burden on patients and families, Parkinson’s Disease is estimated to cost nearly $25 billion per year in the United States alone, with costs related to the healthcare system, Social Security payments, and lost income from inability to work.

Similar social and economic costs affect Europe, which resulted in Parkinson’s Disease becoming a healthcare priority in the EU. The EU’s BIOMARKERS FOR PD project focuses on the development of a biomarker assay that can not only help clinicians identify the disease at an earlier stage but also put in practice more effective treatments, as only therapies that ameliorate symptoms are currently available.

The project also seeks to provide clinical validation of existing and potential biomarker assays, as high sensitivity, specificity, and utility are vital for the development of new and valid diagnostic tools.

“We are grateful for the support from EU,” Gunilla Osswald, CEO of project coordinator BioArctic Neuroscience AB, said in a press release. “The development of a sensitive and specific biomarker that also could mirror the treatment effect would make an enormous advantage in the development of new disease modifying therapeutics.”

BioArctic Neuroscience AB, a Swedish biopharmaceutical company, is developing a disease modifying treatment for PD patients that aims to improve quality of life. The project has received a grant from the European Union’s Horizon 2020 research and innovation program under a grant agreement to develop biomarker assays for Parkinson’s Disease

http://parkinsonsnewstoday.com/2016/02/15/new-biomarker-assay-offers-hope-for-parkinsons-patients/